Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Programmed Intermittent Bolus TPVB for Hepatectomy Analgesia
NCT04304274Completed
- Start
- Mar 2020
- Primary completion
- Jun 2021
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms). Primary endpoint: Postoperative 48hrs morphine consumption. Started Mar 2020; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04304274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04304274.